Thursday, January 11, 2018

US FDA News: Prescription Opioid Cough and Cold Medicines: Drug Safety Communication - FDA Requires Labeling Changes

Risks of slowed or difficult breathing, misuse, abuse, addiction, overdose, and death with these medicines outweigh their benefits in patients younger than 18.
Read more: Prescription Opioid Cough and Cold Medicines: Drug Safety Communication - FDA Requires Labeling Changes